Asia
Combination of Novel Gene Therapy and Immunotherapy Being Evaluated for Synergistic Anti-Tumor Activity in Patients with Cancer with Limited Treatment Options
Companies and organizations from across Europe, Asia and North America share updates on their business and pipelines.
In order to speed up drug development and accelerate target identification, biopharma is increasingly turning to artificial intelligence and machine learning. Most recently, Hong Kong-based Insilico Medicine developed GENTRL, an AI system for drug discovery.
Ultragenyx Pharmaceutical Inc. and Kyowa Kirin Co., Ltd. announced plans to submit a supplemental Biologics License Application to the U.S. Food and Drug Administration for Crysvita® for the treatment of FGF23-related hypophosphatemia associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized.
ASLAN Pharmaceuticals announced that an abstract on its lead candidate, varlitinib, has been accepted for poster presentation at the ESMO Asia Congress 2019 in Singapore on 22 November – 24 November.
The rapid growth of Saudi Arabia’s pharmaceutical market will be placed under the spotlight at the forthcoming CPhI Middle East and Africa event, as the latest industry data reveals the Kingdom’s pharmaceutical market is expected to be valued at $10.74 billion (SR40.1 billion) by 2023.
Novel genomics and computational methods reveal how gene “switches” impact survival rates of cancer patients, paving the way to targeted cancer treatments
Todos Medical Ltd. announced that the Company has entered into a non-binding Memorandum of Understanding with Orot+, the operational division of Orot-Luces, to expand their existing launch and distribution partnership for the commercial sale of Todos’ early breast cancer detection blood tests TM-B1 and TM-B2 into Japan.
In China, much like the United States, it is incredibly difficult to obtain a patent for a diagnostic method.
Last week was a busy week for clinical trial results. Here’s a look at some of the top stories and reporting.
PRESS RELEASES